Back to Type 2 Diabetes
NCT00391196
NCT00391196
Who may be able to join
Who might be able to join this trial:
- You are overweight, with a Body Mass Index (BMI) between 27 and 50 (a number calculated from your height and weight)
- You have been diagnosed with type 2 diabetes
Who may not be able to join:
- You are currently pregnant
- You have a serious or unstable medical condition now or have had one in the past (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Terminated
Phase
Phase 3
Sponsor
Pfizer
Registry
clinicaltrials_gov
Start date
1 November 2006
Est. completion
1 December 2008
Where this trial is recruiting
🇦🇷 Argentina
🇦🇺 Australia
🇧🇷 Brazil
🇨🇦 Canada
🇨🇿 Czechia
🇩🇪 Germany
🇲🇽 Mexico
🇸🇰 Slovakia
🇸🇪 Sweden
🇬🇧 United Kingdom
🇺🇸 United States
5 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Percent change in body weight from baseline.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.